GLER News Alert Global Earth Energy (GLER) 0.0001 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Global Earth Energy (GLER) 0.0001 $GLER

Pinetree Capital Ltd. Acquires Securities of Poet Technologies Inc.
Marketwire Canada - Thu Feb 13, 10:58AM CST
Pinetree Capital Ltd. (TSX NP), announces that on February 13, 2014, it acquired ownership of 2,775,385 common shares ("Common Shares" and 2,775,385 common share purchase warrants (the "Warrants" of Poet Technologies Inc. ("Poet" . Each Warrant entitles the holder thereof to acquire one additional common share at a price of $1.00 until February 13, 2016. In the event that the Warrants are fully exercised, these holdings represent approximately 3.8% of the total issued and outstanding common shares of Poet as of February 13, 2014, calculated on a partially diluted basis assuming the exercise of the Warrants only. As a result of this transaction, Pinetree and its joint actors collectively held, as at February 13, 2014, an aggregate of 14,954,885 common shares of Poet, including the Common Shares, and rights to acquire an additional 13,471,385 common shares of Poet upon the exercise of convertible securities (the "Convertible Securities" . Of these totals, Pinetree owns 8,525,385 common shares, including the Common Shares, and the 7,777,385 of the Convertible Securities (the "Pinetree Convertible Securities" directly. In the event that the Convertible Securities are fully exercised, the holdings of Pinetree and its joint actors represents a total of 28,426,270 common shares of Poet or approximately 18.2% of all issued and outstanding common shares as at February 13, 2014, calculated on a partially diluted basis assuming the exercise of the Convertible Securities only. In the event that the Pinetree Convertible Securities are fully exercised, the direct holdings of Pinetree represent a total of 16,300,770 common shares of Poet, or approximately 10.8% of all issued and outstanding common shares as at February 13, 2014, calculated on a partially diluted basis assuming the exercise of the Pinetree Convertible Securities only.

HAWK Manufacturing Announces Termination of Agreement to Acquire Trump Equipment Company, Inc.
GlobeNewswire - Fri Feb 07, 3:50PM CST
HAWK Manufacturing, Inc. who recently acquired Global Earth Energy, Inc. (OTCQB:GLER) terminated its agreement to purchase a majority interest in Trump Equipment Company, Inc., of New Braunfels, Texas ("Trump" . HAWK, a leading CNC machining company based in Charleston, South Carolina, had entered into an agreement with the majority shareholders of Trump to purchase the company on September 27, 2013.

Hawk Manufacturing, Inc. Closes the Acquisition of Global Earth Energy, Inc. (GLER)
GlobeNewswire - Wed Feb 05, 1:45PM CST
Global Earth Energy, Inc. (OTCQB:GLER) and Hawk Manufacturing (HAWK), announces the closing of the transaction to acquire and merger into Global Earth Energy.

HAWK Manufacturing Closes Acquisition of NQM, Inc. - Aerospace Machine Shop
GlobeNewswire - Wed Feb 05, 12:55PM CST
Global Earth Energy, Inc.'s (OTCQB:GLER) partner HAWK Manufacturing, Inc. (HAWK) announces closing the acquisition of NQM, Inc., an aerospace machine shop. The acquisition is immediately accretive to HAWK's revenues and earnings.

Hawk Manufacturing, Inc. Announces the Acquisition of Global Earth Energy
GlobeNewswire - Wed Jan 22, 9:45AM CST
Hawk Manufacturing is announcing that Hawk Manufacturing and Global Earth Energy (OTCQB:GLER) signed a definitive agreement in which Hawk Manufacturing will acquire Global Earth Energy. The deal is expected to close within the next 10 business days.

Global Earth Energy, Inc. (GLER) Acquires 20% of ByoSafe(TM), LLC
GlobeNewswire - Thu Dec 19, 9:15AM CST
Global Earth Energy, Inc. (OTCQB:GLER) announced acquiring 20% of ByoSafe(TM), LLC.

Global Earth Energy, Inc.'s Partner Hawk Manufacturing Finalizing Agreements on Four Businesses in Three States
GlobeNewswire - Mon Sep 09, 8:15AM CDT
Global Earth Energy, Inc. (OTCQB:GLER) partner HAWK Manufacturing (HAWK) continues to work on reaching acquisition agreements with four businesses in three states. These businesses had combined 2012 annual revenues of $27 million and 2012 annual EBITA profits of $4 million. Expecting to close these acquisitions before the end of 2013, HAWK anticipates using existing financial facilities of more than $10 million to close on these transactions.

Global Earth Energy Inc. Announces Partnership With Hawk Manufacturing, Inc.
GlobeNewswire - Wed Aug 28, 8:15AM CDT
Global Earth Energy, Inc. (OTCQB:GLER), a development stage company operating in the oil and gas sector, announces a partnership with Hawk Manufacturing, Inc. whereby each company will take a respective 20% stake in the other.

Global Earth Energy, Inc. (GLER) Announces Letter of Intent to Consummate a Third Acquisition
GlobeNewswire - Fri May 03, 8:00AM CDT
Global Earth Energy Inc.'s (GLER.OTCQB) President, Mr. Sydney A. Harland, announces that GLER, through a Letter of Intent, intends to acquire a third income-producing asset, the Sunrise Highway Office Building, located at, 381 Sunrise Highway, Lynbrook, New York 11563. The acquisition will only occur if Global Earth Energy and the seller of the property can execute a binding agreement of sale and purchase. As of this date, no such agreement has been executed. If an agreement is executed, proper notification will be made.

Global Earth Energy, Inc. (GLER) Announces a Second Acquisition and Current 2012 Data on Naylor Apartment Complex Which Was Announced on April 30, 2013
GlobeNewswire - Wed May 01, 8:26AM CDT
Global Earth Energy Inc.'s (GLER.OTCQB) President, Mr. Sydney A. Harland, announces that GLER will acquire a second income-producing asset, the Honeywell Apartment Complex, located at, 2103-15 & 2115-17 Honeywell Avenue, Bronx, New York 10460.

Global Earth Energy Inc. (GLER) Announces Acquisition of Income-Producing Asset to Company
GlobeNewswire - Tue Apr 30, 8:00AM CDT
Global Earth Energy Inc.'s (GLER.OTCQB). President, Mr. Sydney A. Harland, announces that GLER will acquire an income-producing asset, the Naylor Apartment Complex, located at, 2585 Naylor Road SE, Washington, DC 20020.

Global Earth Energy, Inc. (GLER) Announces Non-Binding Agreement With Proposed Prospective Appointment of New Director
GlobeNewswire - Wed Apr 03, 8:00AM CDT
Global Earth Energy, Inc. (GLER.OTCQB). Mr. Sydney A. Harland, the President of Global Earth Energy is pleased to announce that Global Earth Energy, Inc. has entered into a non-binding agreement calling for the proposed prospective appointment of, Mr. Meier (Mack) Frankel to the Board of Directors of Global Earth Energy, Inc. Mr. Frankel is an accomplished real estate investor, acquisitor and financier.

Global Earth Energy Announces New Business Strategy
Marketwire - Thu Feb 14, 7:01AM CST
Global Earth Energy Inc. (OTCQB: GLER) is pleased to announce a new extensive growth strategy centered around the acquisition of overriding royalty interest in oil and gas leases in the United States.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading